Nuclera
Biotech company developing cutting-edge benchtop protein printing technologies
Cambridge, UKwww.nuclera.com ↗
Total raised
€133M
€133,275,495
Funding rounds
5
Investors
19
distinct backers
Active since
2022-02
latest 2026-01
Funding by year
EUR raised per year · 2026 YTDSignals
High confidenceRaise-next likelihood28
base rate 51% for Series C
- ▼ Raised very recently
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood24
base rate 12% (2+ rounds)
- ▲ 5 rounds raised
- ▲ €100M+ raised
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
5 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-01-13 | Series C | €10M | British Business Bank,Elevage Medical Technologies,GK Goh,Jonathan Milner | View deal → |
| 2024-10-16 | Series A | €69M | Cambridge Innovation Capital,E Ink Holdings,Elevage Medical Technologies,GK Goh,Jonathan Milner,M&G Catalyst+4 more | View deal → |
| 2024-06-06 | Grant | €1.3M | Innovate UK | View deal → |
| 2022-07-06 | Series B | €15M | Jonathan Milner,Verve Ventures | View deal → |
| 2022-02-02 | Series B | €38M | Amadeus Capital Partners,British Business Bank Future Fund,E Ink,Future Planet Capital,G. K. Goh,M&G Investments+1 more | View deal → |
Investors
19Amadeus Capital PartnersBritish Business BankBritish Business Bank Future FundCambridge Innovation CapitalE InkE Ink HoldingsElevage Medical TechnologiesFuture Planet CapitalG. K. GohGK GohInnovate UKJonathan MilnerM&G CatalystM&G InvestmentsMichael D. McCrearyPatient Square CapitalRT PartnersUni Power GroupVerve Ventures